» Articles » PMID: 1401344

Histologic Features of Cutaneous Sinus Histiocytosis (Rosai-Dorfman Disease): Study of Cases Both with and Without Systemic Involvement

Overview
Journal J Cutan Pathol
Publisher Wiley
Specialty Dermatology
Date 1992 Jun 1
PMID 1401344
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) is a systemic proliferation of cells that resemble the sinus histiocytes of lymph nodes. Whereas initial reports highlighted the often striking cervical adenopathy, more than 40% of patients have extranodal involvement. Cutaneous lesions are the most common form of extranodal disease, but cases that present as cutaneous disease without lymph node involvement are rare. We examined biopsies from three patients with cutaneous lesions of sinus histiocytosis, none of whom had detectable systemic involvement, and compared them to those of two patients whose lymph nodes were involved by the disease. The histology of skin lesions in all five cases showed dense nodular or diffuse infiltrates of "histiocytes," emperipolesis of lymphocytes, neutrophils, and plasma cells. "Histiocytes" were present in lumens of dilated lymphatics. At the peripheries of the lesions were lymphoid aggregates and thick-walled vessels surrounded by plasma cells. Staining with anti-S-100 protein antibody showed marked cytoplasmic positivity in the "histiocytes" in each case. The only features that differed among the two groups were the presence of pseudoepitheliomatous hyperplasia and infiltrates of eosinophils in one case in which the disease was limited to the skin. We believe that cutaneous sinus histiocytosis can be specifically diagnosed by skin biopsy. Because cutaneous sinus histiocytosis may be unfamiliar to general pathologists, dermatopathologists, and dermatologists, cases limited to the skin may be under-recognized.

Citing Articles

A pure Cutaneous Rosai-Dorfman disease: case report and a review of the literature.

Montazer F, Farahani S, Shaka Z, Aryanian Z, Goodarzi A Caspian J Intern Med. 2022; 13(4):818-826.

PMID: 36420329 PMC: 9659825. DOI: 10.22088/cjim.13.4.818.


NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study.

Wu K, Li S, Liao J, Chiou C, Wu C, Chen C Biology (Basel). 2021; 10(5).

PMID: 34063325 PMC: 8147632. DOI: 10.3390/biology10050396.


Histological variability and the importance of clinicopathological correlation in cutaneous Rosai-Dorfman disease.

Gameiro A, Gouveia M, Cardoso J, Tellechea O An Bras Dermatol. 2016; 91(5):634-637.

PMID: 27828638 PMC: 5087223. DOI: 10.1590/abd1806-4841.20164477.


Rosai-Dorfman disease successfully treated with thalidomide.

Chen E, Pavlidakey P, Sami N JAAD Case Rep. 2016; 2(5):369-372.

PMID: 27709124 PMC: 5043389. DOI: 10.1016/j.jdcr.2016.08.006.


[Cheilitis granulomatosa and Melkersson-Rosenthal syndrome. Intralymphatic histiocytosis as valuable diagnostic indication].

Franz R, Andres C Pathologe. 2014; 35(2):177-81.

PMID: 24619529 DOI: 10.1007/s00292-013-1850-6.